ENOV (Health Care Equipment) Stock Valuation & Fair Value Fairly valued
ENOV (Health Care Equipment) trades at a blended P/E of 8.4, about 58% below its historical normal valuation, with a forward growth estimate of 10.5% and a PEG of 0.80. Analysts' one-year estimates have been hit 55% of the time.
Valuation flags
- No notable valuation flags.
Frequently asked questions
Is ENOV overvalued?
At a blended P/E of 8.4 versus its historical normal P/E of 19.7, ENOV trades about 58% below its typical valuation, with a PEG of 0.80 on 10.5% forward growth. tickerseer currently rates it fairly valued.
What is ENOV's fair value and PEG?
ENOV trades at a blended P/E of 8.4 against a historical normal P/E of 19.7, a PEG of 0.80, and a forward growth estimate of 10.5%.
Has tickerseer's rating of ENOV changed?
tickerseer's rating has been fairly valued since 2026-07-31.
Industry: Health Care Equipment. Create a free account to see the full analysis: the SeerAI score, its five quality sub-scores, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.
Get the free weekly earnings preview
One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in the paid plan.
It's free, and you can unsubscribe any time. Educational content, not investment advice.